Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study of Reduced Anti-coagulation/Anti-platelet Therapy in Patients With the HeartMate II Left Ventricular Assist System (LVAS) (TRACE) (TRACE)

This study has been completed.
Thoratec Corporation
Information provided by (Responsible Party):
St. Jude Medical ( Thoratec Europe Ltd ) Identifier:
First received: November 17, 2011
Last updated: April 18, 2016
Last verified: April 2016
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2015
  Primary Completion Date: July 2015 (Final data collection date for primary outcome measure)